3.0.0 2640 2023-01-15T16:33:39Z 2023-01-15T16:33:39Z House H HR 2003-06-26 108 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2003-07-11T15:12:24Z Referred to 2003-06-26T14:03:40Z hswm00 Ways and Means Committee House Standing hswm02 Health Subcommittee Referred to 2003-07-02T20:00:45Z Referred to 2003-06-26T14:03:45Z 2003-07-11 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2003-07-02 hswm02 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2003-06-26 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2003-06-26 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100-A 9 Library of Congress 2003-06-26 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2003-06-26 Introduced in House IntroReferral Intro-H 9 Library of Congress 2003-06-26 Introduced in House IntroReferral 1000 9 Library of Congress K000113 Rep. Kennedy, Patrick J. [D-RI-1] PATRICK KENNEDY D RI J. 1 N F000392 Rep. Frost, Martin [D-TX-24] MARTIN FROST D TX 24 2003-06-26 True N000147 Del. Norton, Eleanor Holmes [D-DC-At Large] ELEANOR NORTON D DC HOLMES 0 2003-06-26 True C001038 Rep. Crowley, Joseph [D-NY-7] JOSEPH CROWLEY D NY 7 2003-07-08 False S000033 Rep. Sanders, Bernard [I-VT-At Large] Bernard Sanders I VT 0 2003-07-08 False C001055 Rep. Case, Ed [D-HI-2] Ed Case D HI 2 2003-09-30 False F000116 Rep. Filner, Bob [D-CA-51] BOB FILNER D CA 51 2004-09-09 False Health Administrative procedure Administrative remedies Civil actions and liability Commerce Consent decrees Costs Department of Health and Human Services Drug advertising Drug approvals Drug industry Drugs Economics and Public Finance Federal employees Forfeiture Generic drugs Government Operations and Politics Government paperwork Government publicity Government trust funds Health education Income tax Injunctions Intellectual property Labor and Employment Law Medicare Patent infringement Patents Pharmaceutical research Pharmacies Prescription pricing Recruiting of employees Research and development Restrictive trade practices Revolving funds Science, Technology, Communications Social Welfare Tax deductions Taxation User charges Health 00 2003-06-26 Introduced in House 2003-07-29T20:00:03Z Prescription Affordability and Medicine Safety Act of 2003 - Authorizes appropriations for the Food and Drug Administration (FDA) for generic drug application review and the continuation of the education program on the use and therapeutic equivalency of drugs.

Amends the Public Health Service Act to authorize the Secretary of Health and Human Services to make grants to States in support of State pharmacy benefit assistance programs. Requires a percentage of profits from the sale of certain drugs and biological products to be placed in a revolving fund and used to support the grants program.

Limits the tax deductions for advertising for prescription drug manufacturers.

Limits the extension of the 30-month stay of FDA approval for any new (generic) drug, as specified, thereby limiting the brand name drug's patent owner's period of exclusive sales.

Makes a patent owner's failure to timely file a civil action for infringement a bar to later action.

Sets forth requirements for filing drug patent information with the FDA. Makes a patent owner's failure to timely file with the FDA a bar to civil actions for patent infringement.

Requires the first generic drug applicant with a specified certification to forfeit the 180-day marketing exclusivity period to a subsequent generic drug applicant if the first generic drug applicant engages in certain behaviors which delay or prevent the marketing of the generic drug.]]>

Prescription Affordability and Medicine Safety Act of 2003 Display Title Prescription Affordability and Medicine Safety Act of 2003 Official Title as Introduced To provide greater access to affordable pharmaceuticals, and for other purposes. Introduced in House IH Short Titles as Introduced Prescription Affordability and Medicine Safety Act of 2003 Introduced in House 2003-06-26T04:00:00Z 2003-07-11 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.